Why your doctor won't prescribe Xanax long term (and what they'll recommend instead)
If you've ever had a panic attack or lived with constant, grinding anxiety, you understand the appeal of a medication that works in minutes. That's what Xanax (alprazolam) does. You take it, and within 30 to 60 minutes, the anxiety loosens its grip.
So why won't most doctors prescribe it as a long-term solution? And why do they keep recommending a daily medication like Lexapro (escitalopram) instead, one that takes weeks to even start working?
It's not because they don't believe your anxiety is real. It's because the science tells a very clear story about what happens when these two approaches play out over time.
How They Work: Two Completely Different Mechanisms
Xanax is a benzodiazepine. It works by binding to GABA-A receptors in the brain and enhancing the effect of GABA, the brain's primary inhibitory neurotransmitter. Think of it as pressing the brakes on your nervous system. The effect is fast: peak blood levels occur within 1 to 2 hours, and you feel calmer almost immediately.
Lexapro is a selective serotonin reuptake inhibitor (SSRI). It works by gradually increasing serotonin levels in the brain, which over time recalibrates the neural circuits involved in mood and anxiety regulation. It doesn't work in minutes. It works over weeks, typically 2 to 4 weeks for initial effects, with full benefit sometimes taking 6 weeks or more.
This difference in speed is not a flaw in Lexapro's design. It reflects a fundamentally different treatment strategy: Xanax manages symptoms in the moment. Lexapro changes the underlying biology that generates those symptoms.
The Short-Term Numbers Favor Benzodiazepines. The Long-Term Numbers Don't.
In clinical trials, benzodiazepines as a class show rapid and robust anxiety reduction. A meta-analysis of 56 clinical trials including over 12,600 patients with generalized anxiety disorder found that benzodiazepines had a medium effect size (Hedges' g = 0.50), which was actually larger than SSRIs (0.33) or SNRIs (0.36) in the short term.
But here's the critical context: most improvement with a benzodiazepine is obtained by 4 weeks. After that, the benefits plateau while the risks continue to accumulate. In contrast, SSRIs and SNRIs may need 3 to 6 months to reach maximal benefit, but that benefit is sustained.
A large network meta-analysis of pharmacological treatments for generalized anxiety disorder found that escitalopram, along with duloxetine and venlafaxine, was more efficacious than placebo with better acceptability. Benzodiazepines were also efficacious for reducing symptoms, but were poorly tolerated compared to placebo, meaning more people dropped out due to side effects.
The Dependency Problem Is Real
In 2020, the FDA updated the boxed warning for all benzodiazepines to describe the risks of physical dependence, withdrawal, and benzodiazepine use disorder. The warning states that even when taken at recommended dosages, benzodiazepine use can lead to misuse, abuse, and addiction.
Physical dependence can develop within days to weeks of regular use. This doesn't mean you're "addicted" in the way most people think of addiction. It means your brain adapts to the presence of the drug, and removing it causes withdrawal symptoms that can include rebound anxiety (often worse than the original anxiety), insomnia, tremor, and in severe cases, seizures.
The clinical practice guideline on benzodiazepine tapering from the American College of Medical Toxicology notes that short-term benzodiazepine use is typically recommended not to exceed 4 weeks. This reflects the general lack of evidence for long-term clinical benefit, as well as research showing that therapeutic effects may diminish within days to weeks due to changes in receptor density, while risks persist.
Those risks include oversedation, cognitive impairment, falls, motor vehicle accidents, and fatal overdose, particularly when combined with opioids or alcohol. A meta-analysis of benzodiazepines for insomnia in adults over 60 showed a 3.8-fold increase in daytime sedation, a 4.8-fold increase in cognitive impairment, and a 2.6-fold increase in psychomotor effects like falls.
Alprazolam specifically has a half-life of approximately 11 hours in healthy adults, but this extends to about 16 hours in elderly patients and nearly 20 hours in those with liver disease. In Asian populations, peak concentrations and half-life of alprazolam are approximately 15% and 25% higher, respectively, compared to Caucasian populations, which is worth noting for dosing considerations.
What Lexapro Offers Instead
Lexapro doesn't give you that immediate wave of calm. But what it does offer is a steady, sustained reduction in baseline anxiety that doesn't require you to take a pill every time you feel anxious.
Lexapro is FDA approved for both major depressive disorder and generalized anxiety disorder. It's taken once daily at a dose of 10 to 20 mg. It doesn't cause physical dependence in the way benzodiazepines do, though it should still be tapered gradually when discontinuing to avoid withdrawal effects.
In the network meta-analysis of treatments for generalized anxiety disorder, escitalopram was among the top-performing medications for both remission and tolerability. It does not impair cognition, does not increase fall risk, and does not carry a risk of fatal overdose when taken alone.
The most common side effects of Lexapro include nausea, insomnia, fatigue, and sexual dysfunction. These are real trade-offs, but they are manageable and often improve over time. They are also not life-threatening.
So When Is Xanax Appropriate?
Benzodiazepines still have a role, but it's a narrow one. Current guidelines from The Lancet's review on anxiety disorders recommend that benzodiazepines should be given very cautiously and never as monotherapy. Their use should be limited to the first few weeks of SSRI or SNRI treatment, as a bridge until those medications start to take effect. They should be prescribed at a fixed-dose regimen, not as needed, to avoid the development of dependency.
There are also specific situations where short-term benzodiazepine use makes sense: acute panic attacks, procedural anxiety, or situations where rapid relief is medically necessary and the duration of use will be brief and defined.
Long-term benzodiazepine use may be appropriate in rare cases, such as severe treatment-resistant generalized anxiety disorder, certain seizure disorders, or palliative care. But these are exceptions, not the rule.
A Note on Cultural Context
In many Asian American and Vietnamese American families, mental health treatment already carries significant stigma. Adding a controlled substance to the conversation can make an already difficult step feel impossible.
Here's what's worth knowing: Lexapro is not a controlled substance. It is not addictive. It does not cause a "high." It is a daily medication, similar in concept to a blood pressure pill, that gradually adjusts brain chemistry to reduce anxiety over time.
If the idea of taking a "psych med" feels uncomfortable, it may help to think of it this way: anxiety disorders involve measurable changes in brain function. Treatment with an SSRI is not about willpower or character. It's about correcting a chemical imbalance, the same way you'd treat any other medical condition.
And if a family member or cultural expectation is creating pressure to avoid medication, know that untreated anxiety disorders tend to worsen over time and are associated with significant impairment in work, relationships, and physical health. Treatment is not a sign of weakness. It's a practical decision.
The Bottom Line
Xanax works fast. Lexapro works long. That's the fundamental trade-off.
For the vast majority of people with anxiety disorders, the evidence overwhelmingly supports daily SSRI treatment as the safer, more effective long-term strategy. Benzodiazepines have a role as a short-term bridge, but they are not a foundation for treatment.
If you're currently taking Xanax regularly and want to transition to a safer long-term approach, talk to your provider. Do not stop benzodiazepines abruptly, as withdrawal can be dangerous. A gradual taper, combined with starting an SSRI, is the standard and safest approach.
The goal isn't to take away something that helps you. It's to find something that helps you without the risks that come with long-term benzodiazepine use. That option exists, and it works.
Want a long-term plan for your anxiety, not just a quick fix?
Alice Tran, PMHNP-BC, provides anxiety evaluation and medication management in person in Fairfax and via telehealth across Virginia, in English and Vietnamese. No referral needed. Most insurance accepted.
Schedule a ConsultationSee Also
Sources
- Slee A, et al. "Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis." The Lancet, 2019.
- Craske MG, Stein MB. "Anxiety." The Lancet, 2016.
- Stein MB, Sareen J. "Generalized Anxiety Disorder." New England Journal of Medicine, 2015.
- Soyka M. "Treatment of Benzodiazepine Dependence." New England Journal of Medicine, 2017.
- U.S. Food and Drug Administration: 2020 boxed warning update for benzodiazepines; Xanax (alprazolam) and Lexapro (escitalopram) prescribing information. fda.gov
Anh Tran (Alice), PMHNP-BC, FNP-BC
Dual Board-Certified Family and Psychiatric Nurse Practitioner
Alice is a dual board-certified PMHNP and FNP licensed in Virginia, trained under psychiatrist Dr. Errol Segall, MD (50+ years of experience). She treats ADHD, anxiety, depression, and more, in person in Fairfax and via telehealth across Virginia, in English and Vietnamese. Learn more →